Apr 14 |
Institutions own 33% of Tenaya Therapeutics, Inc. (NASDAQ:TNYA) shares but private equity firms control 44% of the company
|
Mar 26 |
20 Countries with the Highest Heart Disease Deaths Per Capita
|
Mar 20 |
Tenaya Therapeutics Inc Reports Full Year and Q4 2023 Financial Results
|
Mar 18 |
Tenaya Therapeutics GAAP EPS of -$0.40 beats by $0.04
|
Mar 18 |
Tenaya Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
|
Mar 18 |
Tenaya Therapeutics Announces Publication of TN-401 Gene Therapy Preclinical Data in Nature Communications Medicine
|
Mar 15 |
Blend Labs Reports Q4 Results, Joins Alta Equipment, Despegar.com And Other Big Stocks Moving Higher On Friday
|
Feb 29 |
14 Stocks With Heavy Insider Buying In 2024
|
Feb 27 |
Tenaya Therapeutics to Participate in Upcoming March Investor Conferences
|
Feb 26 |
Should You Buy Tenaya Therapeutics, Inc. (TNYA) After Golden Cross?
|